Clinical Guideline Authors May Have Conflict of Interest with Industry

A recent study by University of Toronto researchers examines the prevalence of conflicts of interest among authors of clinical guidelines related to the drugs with the highest sales numbers in 2016. The study focused on clinical practice guidelines written by 160 US physicians uncovered 79 of them declared receipt of a payment in the guidelines or supplemental materials, with 50 declaring payments from companies marketing one of the drugs included in the analysis.  Of note, 41 of the authors were found to have received—yet not disclosed—receipt of payments marketing one of the drugs.